The history of the erectile dysfunction drug presents a challenging picture for investors. While the initial introduction generated significant returns, the lapse of its patent opened the avenue to generic versions, https://worldsocialindex.com/story6738803/viagra-and-the-pharmaceutical-industry-a-risky-opportunity